N/A
Completed N=742
mHealth Intervention to Support Diabetes Medication Adherence
Source: ClinicalTrials.gov NCT05006872 ↗Enrolled (actual)
742
Serious AEs
—
Results posted
Feb 2025
Primary outcomePrimary: Glycated Hemoglobin (HbA1c) (%) — 8.1; 8.0; 7.5; 7.4 Percentage of HbA1c
Summary
This study aims at evaluating the effectiveness of an intervention based on the use of a mobile-device based system delivering automated, tailored brief text messages to offer support for medicine use and lifestyle recommendations alongside usual care to people with type 2 diabetes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Glycated Hemoglobin (HbA1c) (%) |
8.1; 8.0; 7.5; 7.4 | — |
| PRIMARY Mean Adherence to Antidiabetic Drugs (%) |
95.1; 96.2; 90.4; 91.0 | — |
| SECONDARY Number of Participants Classified as Adherent Based on Self-reported Adherence to Antidiabetic Medication (7 Items ad Hoc Questionnaire) |
205; 194; 220; 197 | — |
| SECONDARY Health-related Quality of Life (EQ-5D-5L) |
0.93; 0.93; 1; 0.97 | — |
| SECONDARY Self-efficacy to Manage Diabetes (DSES-S) |
6.9; 6.9; 8.6; 8.0 | — |
Eligibility Criteria
Inclusion Criteria
- Patients registered in the Public Health Service of the Balearic Islands
- With type 2 diabetes
- At least one prescription of a glucose-lowering drug
- With results of HbA1c>8% from 6 months prior to recruitment
Exclusion Criteria
- Younger than 18 years old
- With insulin treatment
- Participating in another research study
- Not living in the Balearic Islands at some point during the study development
Data sourced from ClinicalTrials.gov (NCT05006872). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.